ANTHRANILIC ACID AND THIOANTHRANILIC ACID N-ARYLAMIDES Russian patent published in 2006 - IPC C07D213/38 C07D213/64 C07D213/89 C07D215/12 C07D233/54 C07D405/12 A61K31/44 A61K31/47 A61K31/415 A61P35/00 

Abstract RU 2286338 C2

FIELD: organic chemistry, medicine, biochemistry, pharmacy.

SUBSTANCE: invention relates to benzamide derivatives possessing with inhibitory activity with respect to tyrosine kinase Flt-1-receptors VEGF that can be used in treatment of neoplastic disease. Invention describes a pharmaceutical substance comprising compounds of the group 2-[(4-pyridyl)methyl]-amino-N-[R1]-benzamide wherein R1 means 4-chlorophenyl, 4-methylphenyl, 4-chloro-3-(trifluoromethyl)phenyl or 3-(trifluoromethyl)phenyl possessing with the inhibitory activity with respect to tyrosine kinase Flt5-2-receptors VEGF associated with neoplastic disease and angiogenesis. Also, invention describes novel compounds of the group 2-[(nitrogen-containing heterocycle)methyl]-amino-N-[R1]-benzamide wherein nitrogen-containing heterocycle is represented by 4-pyrodyl, 4- or 5-quinolinyl, 2-imidazolyl, and a method for their synthesis. Also, invention describes a pharmaceutical composition comprising abovementioned compounds possessing the inhibitory activity with respect to tyrosine kinase VEGF receptors used in treatment of neoplastic disease.

EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.

17 cl, 2 tbl, 74 ex

Similar patents RU2286338C2

Title Year Author Number
ANTHRANILIC ACID AMIDES AND THEIR USING IN PHARMACEUTICALS 2002
  • Bol'D Guido
  • Fjure Paskal'
  • Manli Pol Uill'Jam
RU2315756C2
NEW ANTHRANILAMIDOPYRIDINEUREAS AS VEGF RECEPTOR KINASE INHIBITORS 2005
  • Khut Andreas
  • Intse Shtuart
  • Tiraukh Karl-Khajnts
  • Khess-Shtump Khol'Ger
  • Khaberej Martin
  • Krjuger Martin
  • Rajkhel' Andreas
  • Bol'Mann Rol'F
RU2415850C2
ANTHRANILIC ACID AMIDES, METHOD FOR THEIR PREPARING AND THEIR USING, METHOD FOR TREATMENT OF NEOPLASM DISEASE AMD PHARMACEUTICAL DRUG POSSESSING INHIBITORY ACTIVITY WITH RESPECT TO TYROSINE KINASE VEGF RECEPTOR 2002
  • Bol'D Guido
  • Fjure Paskal'
  • Manli Pol Uill'Jam
RU2318811C2
TYROSINE KINASE INHIBITORS 2008
  • Brajtenshtajn Verner
  • Fjure Paskal'
  • Dzhejkob Sandra
  • Manli Pol Uill'Jam
RU2445309C2
ANTHRANILIC ACID ORTHO-SUBSTITUTED AMIDES AND THEIR USING AS MEDICINAL AGENTS 2001
  • Krjuger Martin
  • Khut Andreas
  • Petrov Orlin
  • Zajdel'Mann Diter
  • Tiraukh Karl-Khajnts
  • Khaberej Martin
  • Menrad Andreas
  • Ehrnst Aleksander
RU2264399C2
ANTHRANYLAMIDEPYRIDINE AMIDES WITH SELECTIVE EFFECT AS INHIBITORS OF VEGFR-2 AND VEGFR-3 2002
  • Ehrnst Aleksander
  • Khut Andreas
  • Krjuger Martin
  • Tiraukh Karl-Khajnts
  • Menrad Andreas
  • Khaberej Martin
RU2299208C2
SUBSTITUTED AMIDES OF BENZOIC ACID AND PHARMACEUTICAL PREPARATION CONTAINING THEM 2001
  • Khut Andreas
  • Zajdel'Mann Diter
  • Tiraukh Karl-Khajnts
RU2353618C2
COMBINATIONS AND COMPOSITIONS EFFECTING ON FUNCTION OF VEGF/VEGF RECEPTOR AND ANGIOPOIETIN/TIE(II) RECEPTOR SYSTEMS AND USES THEREOF 2001
  • Zimajster Gerkhard
  • Khaberehj Martin
  • Tiraukh Karl-Khajnts
RU2292221C2
PHTHALAZINES ELICITING ANGIOGENESIS INHIBITORY ACTIVITY 1998
  • Bol'D Guido
  • Fraj Jorg
  • Traksler Peter
  • Al'Tmann Karl-Khajnts
  • Mett Khel'Mut
  • Stouver Dejvid Rejmond
  • Vod Zhanette
RU2207132C2
DERIVATIVES OF 2-AMINONICOTINE AMIDE AND THEIR USING AS INHIBITORS OF TYROSINE KINASE VEGF RECEPTORS 2001
  • Manli Pol Uill'Jam
  • Bol'D Guido
RU2296124C2

RU 2 286 338 C2

Authors

Al'Tmann Karl-Khajnts

Bol'D Guido

Fjure Paskal'

Manli Pol Uill'Jam

Vud Zhanetta Marzhori

Ferrari Stefano

Khofmann Franchesko

Mestan Jurgen

Khut Andreas

Kruger Martin

Sajdel'Mann Diter

Menrad Andreas

Khaberi Martin

Tiraukh Karl-Khajnts

Dates

2006-10-27Published

1999-11-08Filed